Objectives: The aim of this clinical trial is to investigate the therapeutic benefit, safety, and cost-effectiveness of Daoyin Exercise Therapy (DET) combined with Acupuncture (AT) for unilateral shoulder pain.Methods: This study is a multicenter, open-label, single-blinded (assessor-blinded), pragmatic randomized controlled trial with two parallel arms. Eighty-two participants with unilateral shoulder pain will be randomly assigned in a 1:1 ratio to either the DET plus AT intervention group (n=41) or the AT control group (n=41). Participants will receive 12 treatment sessions over 6 weeks (twice a week). A follow-up will be conducted via telephone four weeks after the final visit. The primary outcome will be the Shoulder Pain and Disability Index (SPADI). Secondary outcomes will be the Numeric Rating Scale (NRS), Active Range of Motion (AROM), EuroQol-5 Dimensions-5 Level (EQ-5D-5L), and EuroQol visual analogue scale (EQ-VAS). Safety will be assessed at every visit, and economic evaluation will be conducted as a mixed-methods approach.Results: The results of each of the indices will be presented as tables or figures, and the findings will be published in a peer-reviewed journal.Conclusions: This study may support the use of DET as a viable adjunctive option for managing shoulder pain and may inform clinical standardization and health policy development.
Background: Several prognostic factors, including the early recovery pattern of acute low back pain (ALBP), are related to the chronicity of LBP. However, the association between systemic symptoms and ALBP remains underexplored from a holistic perspective. Hence, this study aimed to investigate this relationship and identify novel clinical prognostic predictors for LBP. Methods: This retrospective cross-sectional study included patients with ALBP admitted to the Department of Korean Medicine Rehabilitation at the Dongguk University Bundang Hospital between 1 January 2021 and 30 April 2025. Data extracted from medical records included demographics, treatment-related information, pain characteristics, past medical history, and systemic symptoms. Statistical analyses included independent t-tests, Mann–Whitney U tests, chi-squared tests, Fisher’s exact tests, correlation analysis, and multiple linear regression models. Results: A total of 194 patients with ALBP were included in the analysis. Among systemic symptoms, dyspepsia was significantly associated with higher pain at discharge and smaller absolute and relative pain changes. Although sleep disturbance and constipation showed associations with higher pain at discharge in univariate analyses, these associations were not statistically significant in regression models. Beyond systemic symptoms, alcohol consumption was significantly associated with lower pain at discharge and greater relative pain change, while hospitalization and symptom duration exhibited non-linear relationships. These findings remained robust in sensitivity and subgroup analyses. Conclusions: Systemic symptoms, especially dyspepsia, may serve as prognostic factors impeding ALBP recovery, representing potential early markers for identifying patients at risk of chronicity. The findings highlight the prospect of multidimensional strategies in reducing pain and enhancing patients’ quality of life in clinical practice.